Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Endometrial cancer.

V Hanf1, A R Günthert, G Emons

  • 1Universitäts-Frauenklinik Göttingen, Germany.

Onkologie
|November 8, 2003
PubMed
Summary
This summary is machine-generated.

Radical surgery with lymph node dissection is key for invasive endometrial cancer (EC) staging and treatment. Vaginal brachytherapy can prevent recurrences, while other treatments are reserved for specific advanced cases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction to: Use of oral contraceptives in BRCA mutation carriers and risk for ovarian and breast cancer: a systematic review.

Archives of gynecology and obstetrics·2021
Same author

Hormone replacement therapy in BRCA mutation carriers and risk of ovarian, endometrial, and breast cancer: a systematic review.

Journal of cancer research and clinical oncology·2021
Same author

Use of fertility treatments in BRCA1/2 mutation carriers and risk for ovarian and breast cancer: a systematic review.

Archives of gynecology and obstetrics·2020
Same author

Genital lichen sclerosus in women: a histopathological analysis of 38 criteria.

Journal of the European Academy of Dermatology and Venereology : JEADV·2020
Same author

Use of oral contraceptives in BRCA mutation carriers and risk for ovarian and breast cancer: a systematic review.

Archives of gynecology and obstetrics·2020
Same author

[S3 guidelines on the diagnosis and treatment of carcinoma of the endometrium : Requirements for pathology].

Der Pathologe·2019
Same journal

Successful treatment with nab-paclitaxel and gemcitabine after FOLFIRINOX failure in a patient with metastasized pancreatic adenocarcinoma.

Onkologie·2013
Same journal

Metastatic germ cell tumour following renal transplantation.

Onkologie·2013
Same journal

miR-145 inhibits proliferation and invasion of esophageal squamous cell carcinoma in part by targeting c-Myc.

Onkologie·2013
Same journal

A meta-analysis of internal mammary lymph node metastasis in breast cancer patients.

Onkologie·2013
Same journal

Patient-related delay in presentation for cutaneous squamous cell carcinoma. A cross-sectional clinical study.

Onkologie·2013
Same journal

Treatment of primary breast cancer at the surgical unit of the Charité 1984-1998.

Onkologie·2013
See all related articles

Area of Science:

  • Gynecologic Oncology
  • Surgical Oncology
  • Radiation Oncology

Background:

  • Invasive endometrial cancer (EC) requires a multi-modal treatment approach.
  • Accurate staging is crucial for determining appropriate therapy.
  • Current treatment guidelines emphasize surgical intervention and selective adjuvant therapies.

Purpose of the Study:

  • To outline the current therapeutic and staging standards for invasive endometrial cancer.
  • To define the role of surgery, radiation, and systemic therapies in EC management.
  • To provide guidance on the optimal sequencing of treatments for different stages and presentations of EC.

Main Methods:

  • Review of current evidence and established clinical practices in endometrial cancer management.

Related Experiment Videos

  • Emphasis on radical surgery including pelvic and para-aortic lymph node dissection (LND).
  • Discussion of the indications and limitations of adjuvant therapies like brachytherapy, external irradiation, hormonal therapy, and chemotherapy.

    • Main Results:

    • Radical surgery with complete lymph node dissection is the primary treatment and staging modality for invasive EC.
    • Vaginal brachytherapy is effective for preventing vaginal recurrences with minimal side effects.
    • External beam radiotherapy is not routinely indicated in primary therapy but reserved for specific cases with residual disease or nodal involvement.
    • Adjuvant hormonal or cytotoxic therapy is considered experimental; palliative treatment prioritizes endocrine therapy, followed by chemotherapy if necessary, preferably within clinical trials.

    Conclusions:

    • Specialized centers should perform radical surgery and lymph node dissection for invasive EC.
    • Treatment decisions should be individualized based on staging, tumor characteristics, and patient factors.
    • Adjuvant and palliative treatment strategies require careful consideration of efficacy, toxicity, and the potential benefit of clinical trial participation.